Sichuan Kelun Pharmaceutical Hits Day High with 3.52% Intraday Surge

Sichuan Kelun Pharmaceutical Co., Ltd. has experienced a notable increase of 3.52% on March 20, 2026, reaching an intraday high of CNY 34.75. This performance stands in contrast to the broader market, as the China Shanghai Composite index declined by 1.24% on the same day. Over the past week, Sichuan Kelun has shown a gain of 3.37%, while its monthly performance reflects an increase of 8.9%. Year-to-date, the stock has risen by 17.1%, significantly outperforming the China Shanghai Composite, which has seen a slight decline of 0.3%. Despite these positive short-term trends, the company has faced challenges, including a reported decline in net sales of 15.48% and negative results over the last two consecutive quarters. Key financial metrics indicate a market capitalization of CNY 36,978 million, a P/E ratio of 26.00, and a dividend yield of 2.41%. The company's return on equity stands at 7.03%, with a price-to-book ratio of 1.56. These figures highlight the current financial landscape for Sichuan Kelun Pharmaceutical amid broader market conditions.